Celledonia™ enhances the development and manufacture of cell-based therapies by providing rapid, label-free insight into the health and functional state of target cells throughout the process. By measuring intrinsic cellular properties without markers or complex assays, Celledonia™ enables therapy developers to make confident, data-driven decisions that improve process consistency and accelerate development timelines.

Implement predictive cell analytics to:

• Gain workflow efficiency through prediction: Streamline analytics and reduce time, cost, and complexity across development and manufacturing workflows
• Predict optimal starting material: assess patient-derived allogeneic material for quality and cellular fitness to improve downstream performance.
• Enable process monitoring through prediction: Inform pluripotent status, expansion and differentiation strategy for stem cells
• Predict key manufacturing timepoints and process triggers: AuraCyt signatures enable stem cell monitoring, providing clear, unbiased predictions of key manufacturing timepoints
• Identify cell intermediates without known biomarkers
• Enable quality by design through Multiplex-Analysis – analyse multiple cell characteristics simultaneously from as little as a 50µm sample
• Employ quantitative analysis – Count cells, measure concentration, and track population dynamics – for single cells and entire populations.

For Case Studies click here